MU Department of Medicine 2011-2013 Annual Report Feb. 2014 | Page 34
34
Annual Report
University of Missouri- Columbia
Research CONT.
Cerner-Tiger Institute to develop and refine
be utilized and recommend disposition of
multiple clinical quality improvement
tools in the electronic medical record to
the patients within the University system
initiatives that include a discharge
standardize desired performance and to
during their observation stay. Also, they
summary quality improvement project,
measure that performance.
are developing a training program and
a multidisciplinary team approach
protocols for care providers to address
and implementation of a protocol for
treatment, disposition, and discharge
evaluation and treatment of fragility
recommendations. The physician
fractures that improves outcomes, a
assistants will evaluate the effectiveness of
situational analysis of patient knowledge
the tool and treatment with data collection
regarding their heart failure diagnosis,
over a 4-6 month period. MU hospitalists
predictors of recurrent admissions for
are involved in two pharmaceutical
patients presenting with DKA or HHS and
research studies in cooperation with the
delirium in post-operative period (DPP)
Clinical Research Center.
in elderly patients with major hip or knee
Our team of physician assistants is
conducting a study of efficient healthcare
for alcohol abuse patients to decrease
readmission rates and institution costs.
The plan is to utilize a screening tool
to identify individuals with a primary
diagnosis of alcohol intoxication who could
be safely discharged after an observation
period of 23 hours or less. They want to
develop a protocol by which this tool will
MU hospitalists are also involved in
surgery.
Spotlight
Medicine and its basic and clinical science departments.
Investigators from other schools and colleges at MU can benefit
from the center’s resources, including the College of Veterinary
Medicine, the College of Engineering, the Sinclair School of
Nursing, the School of Health Professions and numerous other
schools and colleges on campus. The CRC expands opportunities
for existing core basic science and clinical science researchers,
including drug and device development teams to link with
clinicians and patients and translate scientific discoveries into
clinical applications through all phases of clinical trials. The CRC
also provides the space and environment to expand and pursue
trainee education, including National Institutes of Health (NIH)
The Clinical Research Center (CRC) is the focal point of University
of Missouri’s efforts to develop clinical and translational science
programs that improve health through research, education and
public service. The Clinical Research Center expands the capacity
of the university’s Institute for Clinical and Translational Science
(ICATS) to transform scientific discoveries in laboratories on
campus into products, services and practices that improve health
for the people of Missouri and beyond. It provides enormous
opportunity for clinicians, clinician investigators, and basic
scientists in the Department of Medicine and beyond to expand
their research investigational activities in a state-of-the-art
research facility. It aims to facilitate the School of Medicine and
Department of Medicine strategic planning goals to increase the
quality and productivity of scientific research.
The CRC benefits numerous investigators in the School of
training programs to meet educational goals and expand the cadre
of clinician scientists who can foster the expansion of clinical
and translational research. It also aims to bring new informatics
tools to increase the capacity to manage data sources and expand
research opportunities and capacity. The Center is designed to
allow programmatic growth as MU-ICATS continues to stimulate
interdisciplinary science with improved infrastructure for clinical
research programs. Another renovation will create the MU Center
for Translational Biomedicine and will be under the management
of the MU-ICATS leadership team. The MU Center for Translational
Biomedicine will closely interact with the Clinical Research Center
as life science researchers move their work from the pre-clinical
stage into early-stage trials involving human participants. The CRC
also aims to interact with investigators working within the areas
of comparative effectiveness and community-based research to
expand research in these areas.
Honors + Awards
Carla Dyer, MD
Clinical Curriculum Innovation Award; Academy for Healthcare
Fellowship in the American College of Physicians (FACP);
Improvement Duncan Neuhauser Award for innovation in quality
Department of Medicine Quality Improvement Champion;
improvement and patient safety education
Macy Faculty Scholars Program Finalist; Outstanding Pre-